Cargando…
Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia
Blood carnitine and/or acetylcarnitine deficiencies are postulated in the literature as possible causes of higher ammonia levels. The aim of this study was to investigate if the use of valproic acid, the age of the patients, or certain central nervous system pathologies can cause carnitine and/or ac...
Autores principales: | Maldonado, Cecilia, Guevara, Natalia, Queijo, Cecilia, González, Raquel, Fagiolino, Pietro, Vázquez, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779505/ https://www.ncbi.nlm.nih.gov/pubmed/26998483 http://dx.doi.org/10.1155/2016/2920108 |
Ejemplares similares
-
L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report
por: Maldonado, Cecilia, et al.
Publicado: (2017) -
l-carnitine and l-acetylcarnitine supplementation for idiopathic male infertility
por: Khaw, Shen Chuen, et al.
Publicado: (2020) -
Development of a Population Pharmacokinetic Model for Cyclosporine from Therapeutic Drug Monitoring Data
por: Umpiérrez, Martín, et al.
Publicado: (2021) -
Lamotrigine-Valproic Acid Interaction Leading to Stevens–Johnson Syndrome
por: Vázquez, Marta, et al.
Publicado: (2018) -
Role of CYP2C9, CYP2C19 and EPHX Polymorphism in the Pharmacokinetic of Phenytoin: A Study on Uruguayan Caucasian Subjects
por: Guevara, Natalia, et al.
Publicado: (2017)